The Care until Cure Research Program was established in the year 2000 in collaboration with Wyeth Canada. Wyeth Canada is engaged in the discovery, development, and commercialization of human pharmaceuticals through recombinant DNA and other technologies.
This program allows Canadian investigators to conduct research on various medical and psychosocial aspects of bleeding disorders. Grants are given for clinical research, including outcome evaluation, in fields relevant to improving the quality of life of persons with hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C as well as carriers of an inherited bleeding disorder.
Please note that the CHS will not be accepting new applications at this time for 2010. The funds have been earmarked for second year projects which began in 2009. Should new funds become available for 2010, a call for new applications will be issued.
Copyright © 2010 / Canadian Hemophilia Society / All Rights Reserved